Goldman Sachs’s Envoy Medical Warrant COCHW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.3K Hold
125,039
﹤0.01% 6388
2025
Q4
$4.86K Hold
125,039
﹤0.01% 6383
2025
Q3
$4.7K Hold
125,039
﹤0.01% 6276
2025
Q2
$4.41K Hold
125,039
﹤0.01% 6025
2025
Q1
$4.13K Hold
125,039
﹤0.01% 5992
2024
Q4
$5.84K Hold
125,039
﹤0.01% 5947
2024
Q3
$8.13K Hold
125,039
﹤0.01% 5709
2024
Q2
$6.25K Hold
125,039
﹤0.01% 5567
2024
Q1
$13.3K Hold
125,039
﹤0.01% 5420
2023
Q4
$2.5K Buy
+125,039
New +$3.38K ﹤0.01% 5549
2023
Q3
Sell
-125,039
Closed -$5.44K 5585
2023
Q2
$5.44K Hold
125,039
﹤0.01% 5624
2023
Q1
$3.88K Hold
125,039
﹤0.01% 5816
2022
Q4
$4.75K Hold
125,039
﹤0.01% 5818
2022
Q3
$8K Hold
125,039
﹤0.01% 6047
2022
Q2
$13K Hold
125,039
﹤0.01% 6231
2022
Q1
$31K Hold
125,039
﹤0.01% 6344
2021
Q4
$99K Sell
125,039
-306,913
-71% -$225K ﹤0.01% 6135
2021
Q3
$276K Buy
431,952
+4,800
+1% +$3.9K ﹤0.01% 5548
2021
Q2
$397K Buy
+427,152
New +$305K ﹤0.01% 5352

Other funds holding COCHW

Goldman Sachs's COCHW Position: Q1 2026 in Review

Goldman Sachs held its Envoy Medical Warrant (COCHW) position steady in Q1 2026 at 125,039 shares worth $8.3K. The position accounts for ﹤0.01% of the portfolio, ranked #6388.

Goldman Sachs first reported a position in COCHW in Q2 2021 and has held it in 19 quarters since. The position peaked at $397K in Q2 2021. 34 funds tracked by Wall St. Rank hold COCHW as of Q1 2026.

  • Goldman Sachs held 125,039 shares of Envoy Medical Warrant worth $8.3K as of Q1 2026.
  • Goldman Sachs left its Envoy Medical Warrant share count unchanged in Q1 2026.
  • Envoy Medical Warrant made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #6388 holding.
  • Goldman Sachs first reported a position in Envoy Medical Warrant in Q2 2021 and has held it in 19 quarters since.
  • Goldman Sachs's Envoy Medical Warrant position peaked at $397K in Q2 2021.
  • 34 funds tracked by Wall St. Rank held Envoy Medical Warrant as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.